CANCER REGISTRY Annual Report

Transcription

1 CANCER REGISTRY Annual Report 2017 Cancer Treatment Centers of America at Southeastern Regional Medical Center Atlanta, Georgia Philadelphia, Pennsylvania Chicago, Illinois Tulsa, Oklahoma Phoenix, Arizona

2 CANCER COMMITTEE Chairman s Report On behalf of the Cancer Committee a multidisciplinary team of boardcertified physicians and health care professionals it is my privilege to share clinical excellence highlights over the last year as we continue to focus on quality, safety and value-based health care delivery. In calendar year 2017, more than 2,800 new patients from across Georgia, the Southeast and beyond chose Cancer Treatment Centers of America (CTCA) at Southeastern Regional Medical Center (Southeastern) for their cancer care. Throughout the year, we expanded our clinical roster of more than 200 physicians across a variety of specialties, including medical oncologists who specialize in neuroendocrine and breast tumors, in addition to a new radiation oncologist. Sean Cavanaugh, MD Chairman, Cancer Committee Chief, Radiation Oncology Director, Genitourinary Cancer Center Guided by our mission that we never stop searching for powerful and innovative therapies for our patients, we were proud to be the first hospital in Georgia to offer the Targeted Agent and Profiling Utilization Registry (TAPUR ) Study the American Society of Clinical Oncology s (ASCO ) first-ever clinical trial. The study will evaluate molecularly targeted cancer drugs and collect data on clinical outcomes to learn about additional uses of these drugs outside of indications already approved by the U.S. Food and Drug Administration (FDA). The study is available to eligible patients who have an advanced solid tumor, multiple myeloma, or B-cell non-hodgkin s lymphoma, and are no longer benefiting from standard anticancer treatments. To help battle the national crisis of opioid overuse and death, while simultaneously increasing patient satisfaction, we continue to offer our Advanced Surgery Recovery (ASURE ) program. This program, delivered by a multidisciplinary team working collaboratively to implement evidence-informed protocols, is designed to decrease the length of hospital stays and manage pain levels with non-narcotic pain relievers. The team combines post-surgical rehabilitation with pre-habilitation, and addresses patient nutrition and physical activity within the first 24 hours after surgery. Since our committee focuses on everything from prevention to life after cancer, we assessed the needs of the local community and offered a breast cancer screening program throughout the entire month of October. Southeastern also offered a community education session on lung cancer awareness in November. We also launched our High-Risk Breast Cancer Prevention Program that is designed to screen high-risk patients and implement risk-reducing strategies aimed at helping avoid cancer or at getting an early diagnosis, and thereby, improving treatment outcomes. Additionally, members of the committee worked to enhance the existing smoking cessation program, added extra tumor boards across various specialties and improved the genetic counseling referral process. 2 Cancer Treatment Centers of America at Southeastern Regional Medical Center

3 We also removed barriers to oral nutrition supplement consumption, implemented physician use of a pneumonic expansion to improve documentation and improved patient education on palliative care. Above all, we are honored that patients and families have trusted us with their care and grateful for the phenomenal team of physicians, clinicians and staff who call CTCA home. We look forward to continuing to deliver personalized, compassionate and integrative cancer care to more patients in the future. Sincerely, Sean Cavanaugh, MD Chairman, Cancer Committee Chief, Radiation Oncology Director, Genitourinary Cancer Center CONTENTS 4 Cancer Registry Report 5 Cancer Registry 2017 Accomplishments 6 Accreditations, Certifications and Awards 8 Prevention and Screening 10 Primary Sites 12 Patients by Region 14 Cancer Conference Report The information presented throughout the 2017 Cancer Registry Annual Report reflects the data collected from January 1 to December 31, 2016 unless otherwise noted CANCER REGISTRY ANNUAL REPORT 3

4 CANCER REGISTRY Report The Southeastern Cancer Registry Department maintains a data system designed for collection, management and analysis of data on individuals diagnosed with cancer. The Cancer Registry has entered 7,550 analytic and non-analytic cases into the Cancer Registry database since January 1, During 2016, a total of 2,198 cases were accessioned into the Cancer Registry database. Of these cases, 1,300 were analytic and 898 were non-analytic. These patients came from 43 states, as well as Mexico, Bermuda and the Bahamas. The Cancer Registry professionals are responsible for collecting and recording the most complete and accurate cancer data possible. The Registry staff performs the daily functions of the Tumor Registry and ensures data accuracy with continuous quality improvement reviews by Cancer Committee physicians. The Registry provides the Cancer Committee with information from which analysis of patient outcomes and evidence-informed, clinical decision-making can be performed. 2,198 Total Cases at Southeastern Regional Medical Center 1,300 Analytic 898 Non-Analytic Analytic patients are those who are diagnosed and/or receive all or part of their first course of cancer treatment at CTCA. Non-analytic patients are those who receive subsequent cancer treatment at CTCA due to progressive or recurrent disease. 4 Cancer Treatment Centers of America at Southeastern Regional Medical Center

5 CANCER REGISTRY 2017 Accomplishments Initiated processes that ensure the appropriate pieces of information regarding every cancer patient seeking care at Southeastern are captured in our database Established lifetime contact with each patient receiving treatment for newly diagnosed cancer through follow-up procedures within our registry software Developed a registry abstract for each patient receiving cancer-directed therapy Provided on-demand statistical data reports Submitted cancer cases to the Georgia State Cancer Registry Submitted required data to the National Cancer Data Base, error-free, in the timeframes required Staffed Cancer Conference and Breast Conference meetings Served as staff to the Cancer Committee Maintained all documentation for the accreditation of our cancer program by the Commission on Cancer (American College of Surgeons) C A N C E R R E G I S T R Y A N N UA L R E P O R T 5

6 Accreditations, Certifications AND AWARDS Southeastern is accredited, certified and/or recognized by several renowned professional health care and third-party organizations. Commission on Cancer (CoC) In 2016, Southeastern became accredited by the Commission on Cancer (CoC), a quality program of the American College of Surgeons, with the silver level commendation the highest level of commendation possible for a new program. The CoC recognizes cancer programs for their commitment to providing high-quality, comprehensive and integrative patient-centered care. CoC accredited cancer programs are dedicated to providing the best in patient-centered care. This accreditation recognizes programs that meet the CoC standards and are dedicated to prevention, research and education. National Accreditation Program for Breast Centers (NAPBC) Southeastern received a three-year/full accreditation designation in 2016 by the National Accreditation Program for Breast Centers, a program administered by the American College of Surgeons. Accreditation is granted to centers that have voluntarily committed to provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance. Accredited breast centers are dedicated to enhancing the care they provide by addressing patient-centered needs and measuring the quality of the care they deliver. The Joint Commission Southeastern received the Joint Commission s Gold Seal of Approval for Hospital Accreditation in 2013 and This accreditation decision is awarded to a health care organization that demonstrates satisfactory compliance with applicable Joint Commission standards in all performance areas. In 2015, The Joint Commission recognized Southeastern as a Top Performer on Key Quality Measures, using data from The Top Performer program recognizes hospitals for improving performance on evidence-based interventions that increase the changes of healthy outcomes for patients with certain conditions. Specifically, Southeastern was recognized for its surgical care and venous thromboembolism (VTE) performance measure sets. Quality Oncology Practice Initiative (QOPI ) Southeastern was recognized by the QOPI Certification Program (QCP ), an affiliate of the American Society of Clinical Oncology (ASCO) in 2016, as successfully completing a three-year certification program for outpatient hematology-oncology practices that meet nationally recognized standards for quality cancer care. QCP builds on ASCO s Quality Oncology Practice Initiative (QOPI ). 6 Cancer Treatment Centers of America at Southeastern Regional Medical Center

7 In addition, Southeastern is accredited or certified by the following health care organizations: American College of Radiology Radiation American College of Radiology Breast Imaging Oncology Accredited Facility Center of Excellence American College of Radiology Mammography Accredited Facility American College of Radiology MRI Accredited Facility American College of Radiology Computed Tomography Accredited Facility American College of Radiology Positron Emission Tomography Accredited Facility American College of Radiology Breast Ultrasound American College of Radiology Stereotactic Breast Biopsy U.S. Department of Health and Human Services/Public Health Service/Food and Drug Administration Certified Mammography Facility Clinical Laboratory Improvement Act (CLIA) College of American Pathologists In 2017, Southeastern physicians were recognized by: Castle Connolly Top Doctors, Atlanta Magazine: George Daneker Jr., MD (since 2011); Rabih Bechara, MD, FCCP (since 2009); Scott Shelfo, MD, FACS (since 2013); Daniel Miller, MD (since 2007, 2009); Kelly Manahan, MD, FACOG (since 2013); John Geisler, MD, FACOG (since 2011); John McKnight, MD, MBA (since 2017) C A N C E R R E G I S T R Y A N N UA L R E P O R T 7

8 Prevention AND SCREENING Lung and Breast Cancer Awareness and Prevention To address the identified needs of the local Coweta County community (based on a triennial Community Health Needs Assessment (CHNA) conducted in early 2015), Southeastern hosted two community events in 2017 focused on breast cancer screenings and lung cancer prevention education. The defined community represents both the largest number of patients served at Southeastern and the hospital s physical footprint. The results of the CHNA revealed lung and breast cancer are among the top cancer-related causes of death within the community. 46 women participated in breast cancer screenings Throughout Breast Cancer Awareness Month in October, Southeastern provided screening mammograms to members of the community, with a focus on early detection and prevention. The screenings included a digital mammogram featuring tomosynthesis and educational information on the importance of breast cancer awareness and early detection. Forty-six (46) local women participated in the screenings, with two (2) requiring follow-up. In recognition of Lung Cancer Awareness Month, Southeastern hosted a November Dinner and Discussion with the Doctor featuring Patricia Rich, MD, Medical Oncology Director of the Lung Cancer Institute and Vice Chief of Staff at Southeastern. Dr. Rich provided an educational presentation on lung cancer, prevention/risk reduction and smoking cessation to the local community. She also entertained questions from the audience on topics ranging from second-hand smoke exposure to the link between family history, genetics and lung cancer. Patricia Rich, MD Director, Lung Cancer Institute Vice Chief of Staff Director, Lung Cancer Center 8 Cancer Treatment Centers of America at Southeastern Regional Medical Center

9 2017 CANCER REGISTRY ANNUAL REPORT 9

10 Primary Sites Summary by Body System, Sex, Class and Best CS/AJCC Stage Report Sex Class of Case Status Stage Distribution - Analytic Cases Only Primary Site Total (%) M F Analy 1 NA 1 Alive Exp Stg 0 Stg I Stg II Stg III Stg IV 88 2 Unk 3 ORAL CAVITY & PHARYNX 69 (3.1%) Tongue 23 (1.0%) Salivary Glands 8 (0.4%) Floor of Mouth 1 (0.0%) Gum & Other Mouth 8 (0.4%) Nasopharynx 4 (0.2%) Tonsil 21 (1.0%) Oropharynx 1 (0.0%) Hypopharynx 2 (0.1%) Other Oral Cavity & Pharynx 1 (0.0%) DIGESTIVE SYSTEM 568 (25.8%) Esophagus 31 (1.4%) Stomach 50 (2.3%) Small Intestine 20 (0.9%) Colon Excluding Rectum 182 (8.3%) Cecum Appendix Ascending Colon Hepatic Flexure Transverse Colon Splenic Flexure Descending Colon Sigmoid Colon Large Intestine, NOS Rectum & Rectosigmoid 84 (3.8%) Rectosigmoid Junction Rectum Anus, Anal Canal & Anorectum 12 (0.5%) Liver & Intrahepatic Bile Duct 34 (1.5%) Liver Intrahepatic Bile Duct Gallbladder 9 (0.4%) Other Biliary 12 (0.5%) Pancreas 125 (5.7%) Retroperitoneum 3 (0.1%) Peritoneum, Omentum & Mesentery 5 (0.2%) Other Digestive Organs 1 (0.0%) RESPIRATORY SYSTEM 281 (12.8%) Nose, Nasal Cavity & Middle Ear 2 (0.1%) Larynx 10 (0.5%) Lung & Bronchus 268 (12.2%) Trachea, Mediastinum & Other Respiratory Organs 1 (0.0%) BONES & JOINTS 2 (0.1%) SOFT TISSUE (including Heart) 7 (0.3%) Cancer Treatment Centers of America at Southeastern Regional Medical Center

11 Summary by Body System, Sex, Class and Best CS/AJCC Stage Report Sex Class of Case Status Stage Distribution - Analytic Cases Only Primary Site Total (%) M F Analy 1 NA 1 Alive Exp Stg 0 Stg I Stg II Stg III Stg IV 88 2 Unk 3 SKIN EXCLUDING BASAL & SQUAMOUS 28 (1.3%) Melanoma -- Skin 26 (1.2%) Other Non-Epithelial Skin 2 (0.1%) BREAST 522 (23.7%) FEMALE GENITAL SYSTEM 177 (8.1%) Cervix Uteri 32 (1.5%) Corpus & Uterus, NOS 64 (2.9%) Corpus Uteri Uterus, NOS Ovary 58 (2.6%) Vagina 5 (0.2%) Vulva 12 (0.5%) Other Female Genital Organs 6 (0.3%) MALE GENITAL SYSTEM 259 (11.8%) Prostate 255 (11.6%) Testis 2 (0.1%) Penis 2 (0.1%) URINARY SYSTEM 124 (5.6%) Urinary Bladder 50 (2.3%) Kidney & Renal Pelvis 72 (3.3%) Ureter 1 (0.0%) Other Urinary Organs 1 (0.0%) EYE & ORBIT 1 (0.0%) BRAIN & OTHER NERVOUS SYSTEM 2 (0.1%) Brain 1 (0.0%) Cranial Nerves Other Nervous System 1 (0.0%) ENDOCRINE SYSTEM 7 (0.3%) Thyroid 3 (0.1%) Other Endocrine including Thymus 4 (0.2%) LYMPHOMA 54 (2.5%) Hodgkin Lymphoma 6 (0.3%) Non-Hodgkin Lymphoma 48 (2.2%) NHL - Nodal NHL - Extranodal MYELOMA 23 (1.0%) LEUKEMIA 19 (0.9%) Lymphocytic Leukemia 11 (0.5%) Myeloid & Monocytic Leukemia 8 (0.4%) Acute Myeloid Leukemia Chronic Myeloid Leukemia MESOTHELIOMA 2 (0.1%) MISCELLANEOUS 53 (2.4%) Total 2, ,249 1, , Analytic patients are those who are diagnosed and/or receive all or part of their first course of cancer treatment at CTCA. Non-analytic patients are those who receive subsequent cancer treatment at CTCA due to progressive or recurrent disease. 2 No staging scheme available 3 Stage of cancer unknown 2017 CANCER REGISTRY ANNUAL REPORT 11

12 Patients BY REGION 20 MIDWEST 178 NORTHEAST 9 WEST 189 SOUTHWEST 1,772 SOUTHEAST 2, BAHAMAS OTHER COUNTRIES VIRGIN ISLANDS Total New Cases in 2016 by Region for Southeastern Regional Medical Center These numbers represent the number of primary cancers seen at Southeastern Regional Medical Center. Primary cancer refers to the primary site of the malignancy. 12 Cancer Treatment Centers of America at Southeastern Regional Medical Center

13 John McKnight, MD, MBA Medical Oncologist 2017 CANCER REGISTRY ANNUAL REPORT 13

14 CANCER CONFERENCE Report In 2016, the Southeastern Cancer Registry coordinated weekly General, Breast, GI and Thoracic Conferences. These were attended by a multidisciplinary team including physicians, clinicians, nurses and ancillary service team members to ensure comprehensive representation and care. Together, they reviewed cases in detail and discussed stage, prognostic indicators, national guidelines, plans for appropriate diagnostic studies, therapies and clinical trials. These conferences were prospective, patient-oriented treatment planning meetings that provided a free consultation for our patients and education to our medical and hospital employees. Total Patients Presented at General Cancer Conferences Cancer Site # of Cases Adrenal 0 Anus 1 Appendix 3 Base of Tongue 0 Bile Duct 2 Bladder 1 Breast 11 Cecum 1 Cervix 2 Cholangiocarcinoma 3 Colon 20 Colorectal 4 Duodenal 3 Endometrial 1 Esophagus 3 Gallbladder 0 Gastric 5 GE Junction 0 Head & Neck 0 Cancer Site # of Cases Leiomyosarcoma 0 Liver 5 Lung 4 Lymphoma 1 Mesothelioma 0 Neuroendocrine 0 Ovarian 0 Pancreas 13 Prostate 3 Rectum 11 Renal 3 Retroperitoneum 1 Sarcoma 0 Stomach 2 Testis 1 Thyroid 0 Tongue 0 Unknown 16 Uterus 0 Total Number of Cases Cancer Treatment Centers of America at Southeastern Regional Medical Center

15 Total Patients Presented at Thoracic Cancer Conferences Cancer Site # of Cases Adenoid 1 Adrenal 0 Appendix 0 Bladder 0 Bone 1 Breast 3 Cervix 2 Colon 12 Endometrial 0 Esophagus 11 Ethmoid Sinus 1 Head & Neck 2 Kidney 0 Larynx 3 Leiomyosarcoma 3 Liposarcoma 3 Liver 0 Lung 195 Mediastinum 3 Melanoma 0 Mesothelioma 2 Mouth 1 Cancer Site # of Cases Nasopharyngeal 4 Neck 4 Neuroendocrine 1 Nose 1 Oral Cavity 1 Oropharynx 1 Ovary 2 Pancreas 2 Pharynx 1 Prostate 4 Rectum 6 Salivary Duct 1 Salivary Gland 2 Sarcoma 4 Thymic 1 Thymoma 5 Thyroid 2 Tongue 9 Tonsil 6 Unknown 5 Vocal Cords 1 Total Number of Cases 306 Total Patients Presented at Breast Cancer Conferences Cancer Site # of Cases Breast 147 Gallbladder 1 Gastric 1 Liver 1 Lung 1 Pancreas 1 Prostate 1 Unknown 2 Total Number of Cases CANCER REGISTRY ANNUAL REPORT 15

16 Cancer Treatment Centers of America at Southeastern Regional Medical Center 600 Celebrate Life Parkway Newnan, GA cancercenter.com CTCA 2017 Rising Tide